$1.235
-0.055[-4.26%]
Last update: 1:01PM Get Real Time Here
Akebia Therapeutics
(NASDAQ:AKBA)Akebia Therapeutics Stock (NASDAQ:AKBA), Earnings Estimates, EPS, and Revenue
Akebia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$-0.090
Quarterly Revenue
$32.6M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$187.2M
Analyze the earnings history of Akebia Therapeutics using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?
Akebia Therapeutics (AKBA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Akebia Therapeutics (NASDAQ:AKBA)?
Akebia Therapeutics (AKBA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 9, 2024 for Q1 and the Actual EPS was $-0.09, which missed the estimate of $-0.08.
What were Akebia Therapeutics’s (NASDAQ:AKBA) revenues?
Akebia Therapeutics (AKBA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 9, 2024 for Q1 and the Actual Revenue was $32.6M, which missed the estimate of $46.3M.
Browse earnings estimates, EPS, and revenue on all stocks.